Alembic declines after reverse turnaround in Q3

Alembic fell 2.83% to Rs 49.80 at 13:49 IST on BSE after the company reported a net loss of Rs 2.50 crore in Q3 December 2014 compared with net profit of Rs 2.90 crore in Q3 December 2013.

The Q3 result was announced during market hours today, 22 January 2015.

Meanwhile, the S&P BSE Sensex was up 88.94 points or 0.31% at 28,977.80.

On BSE, so far 8.27 lakh shares were traded in the counter as against average daily volume of 3.13 lakh shares in the past one quarter.

The stock hit a high of Rs 51.90 and a low of Rs 47.80 so far during the day. The stock had hit a 52-week low of Rs 11.34 on 31 January 2014. The stock had hit a record high of Rs 69.50 on 23 September 2014.

The stock had outperformed the market over the past one month till 21 January 2015, advancing 32.09% compared with the Sensex's 5.54% rise. The scrip had also outperformed the market in past one quarter, jumping 20.87% as against Sensex's 8.7% rise.

The small-cap company has equity capital of Rs 53.40 crore. Face value per share is Rs 2.

Alembic's total income from operations rose 7.51% to Rs 38.18 crore in Q3 December 2014 over Q3 December 2013.

Alembic is engaged in manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). The company is also engaged in research and Development activity at Vadodara.

Powered by Capital Market - Live News